Literature DB >> 14739624

Thrombin domains: structure, function and interaction with platelet receptors.

Raimondo De Cristofaro1, Erica De Candia.   

Abstract

Thrombin plays a pivotal role in different biological phenomena, such as hemostasis, thrombosis, and cell differentiation. Indeed this protease catalyzes the conversion of fibrinogen into fibrin, the activation of coagulation factors V, VIII, XI, and XIII, but is also involved in the activation of many cell types and platelets. Thrombin bears some recognition domains and insertion loops, not found among other serine proteases of the coagulation system. In this review the properties of these thrombin domains, which regulate the specificity of the enzyme's interaction with substrates and inhibitors, are particularly emphasized. The example of thrombin interaction with the platelet membrane receptors, namely GpIb and PAR1, shows how the concerted action of the insertion loops and recognition domains is the key to solve the apparent enigma as to how thrombin can be at the same time a very efficient and specific enzyme for different substrates and inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14739624     DOI: 10.1023/B:THRO.0000011370.80989.7b

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  124 in total

1.  An extensive interaction interface between thrombin and factor V is required for factor V activation.

Authors:  T Myles; T H Yun; S W Hall; L L Leung
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

2.  Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex.

Authors:  C Sadasivan; V C Yee
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 3.  Structural and functional diversity in the leucine-rich repeat family of proteins.

Authors:  S G Buchanan; N J Gay
Journal:  Prog Biophys Mol Biol       Date:  1996       Impact factor: 3.667

4.  Allosteric modulation of the activity of thrombin.

Authors:  E J Duffy; H Angliker; B F Le Bonniec; S R Stone
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.

Authors:  Mårten Steen; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

6.  Enzymatic properties of proteolytic derivatives of human alpha-thrombin.

Authors:  J Hofsteenge; P J Braun; S R Stone
Journal:  Biochemistry       Date:  1988-03-22       Impact factor: 3.162

7.  Reconstitution of catalytically competent human zeta-thrombin by combination of zeta-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to zeta-thrombin residues B149-259.

Authors:  Z R Gan; S D Lewis; J R Stone; J A Shafer
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

8.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

10.  An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.

Authors:  R Bar-Shavit; V Sabbah; M G Lampugnani; P C Marchisio; J W Fenton; I Vlodavsky; E Dejana
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more
  10 in total

1.  Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke.

Authors:  Victor Serebruany; Yanti Sani; Donald Lynch; Alex Schevchuck; Stan Svetlov; Alan Fong; Lionel Thevathasan; Dan Hanley
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

2.  Cell-based models of coagulation: a paradigm in evolution.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

3.  Platelet P2Y₁₂ receptors are involved in the haemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng.

Authors:  B Gao; L Huang; H Liu; H Wu; E Zhang; L Yang; X Wu; Z Wang
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Modifiers of symptomatic embolic risk in infective endocarditis.

Authors:  Nandan S Anavekar; Jason C Schultz; Daniel D Correa De Sa; Justin M Thomas; Brian D Lahr; Imad M Tleyjeh; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

5.  Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from Anopheles gambiae.

Authors:  Luciano Pirone; Jorge Ripoll-Rozada; Marilisa Leone; Raffaele Ronca; Fabrizio Lombardo; Gabriella Fiorentino; John F Andersen; Pedro José Barbosa Pereira; Bruno Arcà; Emilia Pedone
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

6.  Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.

Authors:  Sergei Zaitsev; M Anna Kowalska; Michael Neyman; Ronald Carnemolla; Samira Tliba; Bi-Sen Ding; Aaron Stonestrom; Dirk Spitzer; John P Atkinson; Mortimer Poncz; Douglas B Cines; Charles T Esmon; Vladimir R Muzykantov
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

7.  Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Authors:  Joyce N Gonzales; Kyung-mi Kim; Marina A Zemskova; Ruslan Rafikov; Brenten Heeke; Matthew N Varn; Stephen Black; Thomas P Kennedy; Alexander D Verin; Evgeny A Zemskov
Journal:  Vascul Pharmacol       Date:  2014-01-25       Impact factor: 5.773

Review 8.  New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

Authors:  María Asunción Esteve-Pastor; Diana Hernández-Romero; Mariano Valdés; Francisco Marín
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

9.  New considerations on pathways involved in acute traumatic coagulopathy: the thrombin generation paradox.

Authors:  Cedric Gangloff; Fanny Mingant; Michael Theron; Hubert Galinat; Ollivier Grimault; Yves Ozier; Karine Pichavant-Rafini
Journal:  World J Emerg Surg       Date:  2019-12-12       Impact factor: 5.469

10.  Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.

Authors:  Elena Zavyalova; Nadezhda Samoylenkova; Alexander Revishchin; Andrey Golovin; Galina Pavlova; Alexey Kopylov
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.